Health Economics

In Canada, Pharmacoeconomic (health economic) analysis is an essential requirement for drug submissions to most regulatory bodies, such as provincial formularies, the Common Drug Review (CDR), and some private drug plan administrators and is an important market research tool.

In a climate of increasing scrutiny over healthcare costs, having the right economic information can facilitate decision-making and provide appropriate evidence to expedite formulary listing.

Brogan Inc. provides data and expertise to evaluate the cost-effectiveness of treating the conditions addressed by your new drug compared to the gold standard of therapy currently available for patients. You can rely on our team of experienced health economists to help you achieve formulary listing objectives effectively.

Source of Information

Brogan Inc. employs appropriate information from a variety of sources including data from hospitals, drug plans, physicians, medical records, patient databases, Statistics Canada, and published literature.

Model Development

We have extensive expertise with a wide range of data sources, economic models and analytical methods. We develop client-specific models with realistic assumptions that increase certainty around the model parameters.

Economic Expertise

•  Product Development / Pricing
•  Burden of illness
•  Cost-Effectiveness Analysis
•  Financial Impact Analysis
•  Outcomes Research


For more information, please contact our Health Economics department at 613.599.0711.